000			03597nam a22004815i 4500
001			978-3-540-31611-4
003			DE-He213
005			20140220084519.0
007			cr nn 008mamaa
008			100301s2010 gw | s |||| 0|eng d
020			_a9783540316114 _9978-3-540-31611-4
024	7		_a10.1007/978-3-540-31611-4 _2doi
050		4	_aRC254-282
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a616.994 _223
100	1		_aBrun del Re, Renzo. _eeditor.
245	1	0	_aMinimally Invasive Breast Biopsies _h[electronic resource] / _cedited by Renzo Brun del Re.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2010.
300			_aXII, 225 p. 206 illus. 152 in color _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aRecent Results in Cancer Research, _x0080-0015 ; _v173
505	0		_aDocumentation and Correlation of Senologic Findings -- Comparison of Large-Core Vacuum-Assisted Breast Biopsy and Excision Systems -- Sonographically Guided Vacuum-Assisted Breast Biopsy Using Handheld Mammotome -- The Vacora Biopsy System -- Available Stereotactic Systems for Breast Biopsy -- MRI-Guided Minimally Invasive Breast Procedures -- Ductoscopy of Intraductal Neoplasia of the Breast -- Pathology of Breast Tissue Obtained in Minimally Invasive Biopsy Procedures -- Limitations of Minimally Invasive Breast Biopsy -- Advances in Breast Imaging: A Dilemma or Progress? -- Cost–Benefit Analyses -- Systematic Review and Meta-analysis of Recent Data.
520			_aModern imaging methods have made it possible to detect breast cancer at an earlier stage than in the past. Nevertheless, when screening is performed regularly over a 10-year period, 20% of examined women will present a suspicious finding that subsequently proves to be benign. Accordingly, beyond cancer detection an important goal is the identification of benign lesions in a manner that is reliable, tissue sparing, patient friendly, and cost-effective. More than 70% of breast biopsies can now be performed using minimally invasive procedures that meet these criteria. Against this background, it can be concluded that a mammography screening programme without the possibility of minimally invasive biopsies is neither ethically nor economically justifiable. This book examines in detail the diverse minimally invasive diagnostic techniques that may be employed when imaging yields suspicious findings. These include vacuum-assisted minimally invasive breast biopsy systems (ATEC, EnCor, Intact, Mammotome and Vacora), stereotactic systems, MRI-guided procedures, and ductoscopy. Further chapters are devoted to the pathology of the breast tissue obtained using these procedures, their limitations, the implications of recent advances in breast imaging, and the results of cost-benefit analyses. The closing chapter provides a systematic review and meta-analysis of recent data.
650		0	_aMedicine.
650		0	_aGynecology.
650		0	_aOncology.
650		0	_aCancer _xSurgery.
650	1	4	_aMedicine & Public Health.
650	2	4	_aOncology.
650	2	4	_aGynecology.
650	2	4	_aSurgical Oncology.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783540314035
830		0	_aRecent Results in Cancer Research, _x0080-0015 ; _v173
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-540-31611-4
912			_aZDB-2-SME
999			_c111168 _d111168